CanSino Biologics Inc

688185

Company Profile

  • Business description

    CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.

  • Contact

    185 South Avenue
    401-420, 4th Floor, Biomedical Park
    TEDA West District
    Tianjin
    CHN

    T: +86 4009222099

    https://www.cansinotech.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    1,105

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,510.7043.700.52%
CAC 407,873.8323.730.30%
DAX 4023,638.5672.020.31%
Dow JONES (US)42,140.43269.67-0.64%
FTSE 1008,602.922.06-0.02%
HKSE23,108.27441.19-1.87%
NASDAQ19,010.09301.741.61%
Nikkei 22538,183.26539.001.43%
NZX 50 Index12,786.74109.990.87%
S&P 5005,886.5542.360.72%
S&P/ASX 2008,269.0035.500.43%
SSE Composite Index3,374.875.630.17%

Market Movers